<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Complications of Diabetes, DKA &amp; HHS</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Complications of Diabetes, DKA &amp; HHS</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                11 Questions | 11 Total Marks | 21 min Duration | ~114.55 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 11 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 21 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 11</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Complications of Diabetes, DKA &amp; HHS - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 11</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 11 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A 19-year-old marine had drowsiness and generalized tiredness, and was brought to the emergency, where after IV administration of saline, he was returned to duty with the diagnosis of dehydration. Upon questioning, he reported unquenchable thirst, and the repeated need to urinate. Although he ate all of his rations as well as whatever he could get from his fellow trainees. On the last day, he complained of vague abdominal pain, which was worse on the morning of admission. He had vomited once. During examination, he was oriented but tachypneic. He appeared pale, dehydrated with dry mucous membranes, and poor skin turgor. His respiratory rate was 36/minute with deep, laborious breathing; his heart rate was 138/minute regular, and his blood pressure was 90/60 Laboratory, on admission, showed glucose of 560 mg/dl, sodium 154, potassium 6. 5, pH 7. 25, bicarbonate 10 mM/liter. What is the possible diagnosis?", "options": [{"label": "A", "text": "Diabetic ketoacidosis", "correct": true}, {"label": "B", "text": "Pyelonephritis", "correct": false}, {"label": "C", "text": "Hyperosmolar nonketotic coma", "correct": false}, {"label": "D", "text": "Melioidosis", "correct": false}], "correct_answer": "A. Diabetic ketoacidosis", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Diabetic ketoacidosis Excessive thirst Polyuria Polyphagia Vomiting Tachypnea Glucose = very high RR = very high = 36/min But still pH = 7. 25 = acidic Therefore we can confirm the diagnosis of Diabetic ketoacidosis due to diabetes mellitus.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option B : pyelonephritis can be due to elevated glucose in urine, but there is no acidosis or tachypnea in pyelonephritis, so ruled out. Option C: hyperosmolar nonketotic coma, there is no ketosis and no acidosis, therefore can be ruled out. Option D : Melioidosis, by burkholderia pseudomallei, causes abscess in the liver and spleen. Not related here. Can be associated with diabetes, but ruled out in this case.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "While discussing a case of diabetes mellitus, a resident asked his consultant about diabetes related complications.Which of the following statements is not true regarding diabetes related complications?", "options": [{"label": "A", "text": "Diabetes related complications can be divided into vascular and non vascular complications", "correct": false}, {"label": "B", "text": "They are similar for both type 1 and type 2", "correct": false}, {"label": "C", "text": "Macrovascular complications are diabetes specific, whereas microvascular complications are shared with both general population and diabetes", "correct": true}, {"label": "D", "text": "Cheiroarthropathy is a nonvascular complication of diabetes", "correct": false}], "correct_answer": "C. Macrovascular complications are diabetes specific, whereas microvascular complications are shared with both general population and diabetes", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Macrovascular complications are diabetes specific, whereas microvascular complications are shared with both general population and diabetes Microvascular complications are diabetes specific , whereas Macrovascular complications are shared with both general population and diabetes specific. Microvascular complications are diabetes-specific, whereas macrovascular complications have pathophysiologic features that are both shared with the general population and diabetes-specifi c.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option:A,B. Diabetes-related complications can be divided into vascular and nonvascular complications and are similar for type 1 and type 2 DM . The vascular complications of DM are further s ubdivided into microvascular (retinopathy, neuropathy, nephropathy) and macrovascular complications (CHD, peripheral arterial disease [PAD], cerebrovascular disease). Option:D.Nonvascular complications include infections, skin changes, and hearing loss e. g. cheiroarthropathy</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A clinical case presentation of complications of diabetes mellitus was organized by residents of the medicine department of RNT medical college, rajasthan. The residents elaborated all possible complications , microvascular , macrovascular, non vascular. HOD of the department asked about the possible mechanism by which chronic hyperglycemia can cause all these complications. Which of the following is least likely to be the possible mechanism?", "options": [{"label": "A", "text": "Hyperglycemia leads to epigenetic changes that influence gene expression in affected cells", "correct": false}, {"label": "B", "text": "Chronic hyperglycemia leads to formation of advanced glycosylation end products (eg, pentosidine, glucosepane, and carboxymethyllysine) which bind to specific cell surface receptor", "correct": false}, {"label": "C", "text": "Chronic hyperglycemia decreases glucose metabolism via the sorbitol pathway related to the enzyme aldose reductase", "correct": true}, {"label": "D", "text": "Chronic hyperglycemia increases the formation of diacylglycerol, leading to activation of protein kinase c, which alters the transcription of genes", "correct": false}], "correct_answer": "C. Chronic hyperglycemia decreases glucose metabolism via the sorbitol pathway related to the enzyme aldose reductase", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Chronic hyperglycemia decreases glucose metabolism via the sorbitol pathway related to the enzyme aldose reductase The correct statement is - Chronic hyperglycemia INCREASES glucose metabolism via the sorbitol pathway related to the enzyme aldose reductase. All other statements are true.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A . hyperglycemia leads to epigeneti c changes (Chap. 456) that influence gene expression in affected cells - TRUE Chronic hyperglycemia is the important etiologic factor leading to complications of DM, but the mechanism(s) by which it leads to such diverse cellular and organ dysfunction is unknown. An emerging hypothesis is that hyperglycemia leads to epigenetic changes that influence gene expression in affected cells. Option: B. chronic hyperglycemia leads to formation of advanced glycosylation end products (e. g. , pentosidine, glucosepane, and carboxymethyllysine) which bind to specific cell surface receptors. -TRUE Option: D . Chronic hyperglycemia increases the formation of diacylglycerol, leading to activation of protein kinase C , which alters the transcription of genes - TRUE.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 12 year old male was brought to the casualty with a history of abdominal pain, vomiting since the last few hours. He is found to be dehydrated. The mother says that the child has been losing weight over the last few months. He is also found to have a thyroid swelling. His GRBS is 450 mg/dl and urine ketones are positive. ABG shows metabolic acidosis. He is started on iv fluids and insulin infusion. Given his age and type of presentation, a diagnosis is made. Which is an immunological marker of type I diabetes this condition?", "options": [{"label": "A", "text": "Anti endothelial antibody", "correct": false}, {"label": "B", "text": "Anti GAD", "correct": true}, {"label": "C", "text": "Anti saccharomyces antibody", "correct": false}, {"label": "D", "text": "None of the above", "correct": false}], "correct_answer": "B. Anti GAD", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Anti GAD This child has been presented with Diabetic Ketoacidosis which is a common first time presentation of type 1 diabetes mellitus. The associated thyroid swelling probably points to co-existent autoimmune thyroid disease. Individuals with Type 1 DM have the following characteristics- Onset prior to 30 years of age Lean body habitus Requirement of insulin as initial therapy Propensity to develop DKA Increased risk of other autoimmune conditions such as autoimmune thyroid disease, vitiligo, coeliac disease etc Immunologic markers in type 1 DM: Islet cell autoantibodies (ICAs) Glutamic acid decarboxylase, (GAD) Beta cell specific zing transporter (ZnT â€“ 8) Antibody to insulin (IAA) Tyrosine phosphatase (IA-2 & IA- 2B)</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A . Anti endothelial antibody - Antiendothelial cell antibodies (AECAs) are commonly detectable in diseases associated with vascular injury, including systemic lupus erythematosus (SLE), systemic sclerosis, Takayasu arteritis, Wegener granulomatosis, BehÃ§et syndrome, and transplant arteriosclerosis. Option: C . Anti saccharomyces antibody - Anti-Saccharomyces cerevisiae antibodies (ASCA) are immune proteins that are frequently present in people who have inflammatory bowel disease (IBD) .</p>\n<p><strong>Extraedge:</strong></p><p>Prevention of type 1 DM: In patients with new-onset type 1 diabetes, treatment with anti-CD3 monoclonal antibodies has been tried.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "You are posted in a diabetes clinic of a medical college where the treating physician has asked you to perform the annual foot examination of all diabetics who come to the diabetes clinic. All of the following are components of diabetic foot examination except", "options": [{"label": "A", "text": "Assess blood flow by checking peripheral pulses", "correct": false}, {"label": "B", "text": "Check sensation using 256 Hz tuning fork at the base of the great toe", "correct": true}, {"label": "C", "text": "Perform Monofilament test using 5.07,10g monofilament", "correct": false}, {"label": "D", "text": "Check for ankle reflex, nail care and ulceration and Charcot joint", "correct": false}], "correct_answer": "B. Check sensation using 256 Hz tuning fork at the base of the great toe", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Check sensation using 256 Hz tuning fork at the base of the great toe Sensation-vibration sensation [128 Hz tuning fork (NOT 256) at base of great toe]</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option:A. Assess blood flow(pedal pulses) Option:C. Ability to sense touch with a monofilament [5.07,10g monofilament], pin prick sensation, ankle reflexes and nail care Look for presence of foot deformities such as hammer or claw toes and Charcot foot Option:D. Identify sites of potential ulceration</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 45 year old female is newly diagnosed with type 2 diabetes, FBS of 310 and HbA1c 11% is yet to be started on insulin therapy. She is started on a mixed dose of long acting + short acting insulin. Following guidelines are to be followed while mixing short and long acting insulin except?", "options": [{"label": "A", "text": "Mix the different formulations of insulin in the syringe immediately before injection and inject within half an hour of mixing", "correct": true}, {"label": "B", "text": "Do not store insulin as a mixture", "correct": false}, {"label": "C", "text": "Do not mix insulin glargine,detemir or degludec with other insulins", "correct": false}, {"label": "D", "text": "All the above are true statements", "correct": false}], "correct_answer": "A. Mix the different formulations of insulin in the syringe immediately before injection and inject within half an hour of mixing", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Mix the different formulations of insulin in the syringe immediately before injection and inject within half an hour of mixing The alterations in insulin absorption the patient mixes different insulin formulations should NOT prevent mixing insulins The following guidelines MUST be followed while mixing insulins Option:A.Mix the different insulin formulations in the syringe immediately before injection (inject within 2 min after mixing)</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option:B.Do not store insulin as a mixture Follow the same routine in terms of insulin mixing and administration to standardize the physiologic response to injected insulin Option:C.Do not mix insulin glargine, detemir, or degludec with other insulins</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following is a GLP-1 receptor agonist?", "options": [{"label": "A", "text": "Sitagliptin", "correct": false}, {"label": "B", "text": "Glulisine", "correct": false}, {"label": "C", "text": "Exenatide", "correct": true}, {"label": "D", "text": "None of the above", "correct": false}], "correct_answer": "C. Exenatide", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Exenatide Anti diabetic drugs which increase GLP -1 and GIP Exenatide (Injection) Liraglutide (Injection) Dulaglutide (Injection)</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option B - Glulisine - is a fast acting insulin preparation.</p>\n<p><strong>Extraedge:</strong></p><p>ORAL SEMAGLUTIDE is the first oral GLP-1 receptor agonist approved by FDA for treatment of type 2 diabetes B.New anti diabetic drugs which increase GLP1 and GIP level by inhibiting DPP â€“ IV (DPP â€“ IV inhibitors) Sitagliptin Vildagliptin Saxagliptin Ritagliaptin Alogliptin Linagliptin - can be given in renal failure</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "The major classes of oral antidiabetic medications include biguanides, sulfonylureas, meglitinide, thiazolidinedione (TZD), dipeptidyl peptidase 4 (DPP-4) inhibitors, sodium-glucose cotransporter (SGLT2) inhibitors, and Î±-glucosidase inhibitors. Which of the following is an antidiabetic drug?", "options": [{"label": "A", "text": "Bromocriptine", "correct": true}, {"label": "B", "text": "Phenytoin", "correct": false}, {"label": "C", "text": "Ropinirole", "correct": false}, {"label": "D", "text": "None of the above", "correct": false}], "correct_answer": "A. Bromocriptine", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Bromocriptine Recently Bromocriptine has been approved as an antidiabetic drug. It improves glycemic control and glucose tolerance in obese type 2 diabetic patients. Both reductions in fasting and postprandial plasma glucose levels appear to contribute to the improvement in glucose tolerance. The bromocriptine-induced improvement in glycemic control is associated with enhanced maximally stimulated insulin-mediated glucose disposal. However,its role in treatment of type 2 DM is uncertain</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: B . Phenytoin - Phenytoin is used to control certain types of seizures, and to treat and prevent seizures that may begin during or after surgery to the brain or nervous system. Phenytoin is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain. Option: C . Ropinirole acts on the nervous system at dopamine receptors (a neurotransmitter or a chemical messenger). It stimulates the dopamine receptors that help restore the balance of natural dopamine in the brain needed to control movements. This medication is available as immediate-release and extended-release tablets.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 48 year old diabetic since 12 years presents with ptosis and ophthalmoplegia suggestive of a 3rd cranial nerve palsy. However direct and indirect pupillary reflexes are normal. Third nerve palsy with normal pupillary reaction is seen in which condition.", "options": [{"label": "A", "text": "Aneurysm", "correct": false}, {"label": "B", "text": "Diabetes", "correct": true}, {"label": "C", "text": "Trauma", "correct": false}, {"label": "D", "text": "Raised ICT", "correct": false}], "correct_answer": "B. Diabetes", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Diabetes Cranial Neuropathy = III & VI cranial nerves are commonly involved in diabetes. In DM IIIrd nerve is involved most commonly but pupillary reaction remains normal. In diabetes the central fibers are affected first and not the pupillary fibers. Hence, there is pupillary sparing.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option;A,C. pupillary fibers are peripherally distributed and first affected in case of aneurysm, trauma etc leading to pupillary dilation and loss of pupillary reflex Option:D. Same goes with raised ICP - causes loss of pupillary reflex Option A ,C and D - The 3rd nerve palsy is associated with a loss of pupillary reflex.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Scleredema is an uncommon, but likely underrecognized, fibro mucinous connective-tissue disease. It is characterized clinically by woody induration and hardening of the skin that results from excessive mucin deposition between thickened collagen bundles in the skin